Mechanisms of Vascular Defects in Diabetes Mellitus
-15%
portes grátis
Mechanisms of Vascular Defects in Diabetes Mellitus
Pillai, Radhakrishna M.; Ramachandran, Surya; Kartha, C.C.
Springer International Publishing AG
08/2017
579
Dura
Inglês
9783319603230
15 a 20 dias
This book intends to bring together, a panel of renowned experts in the field of vascular biology and diabetology, to integrate the current understanding of the pathogenesis and pathophysiology of vascular diseases in diabetes mellitus.
SECTION I: Pathophysiology Chapter 1. The global burden of diabetes and its vascular complications Dr V. Mohan Madras Diabetes Research Foundation No 4, Conran Smith Road, Gopalapuram, Chennai - 600 086 India Email: drmohans@diabetes.ind.in Chapter 2. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis School of Medical Sciences University Sains Malaysia Kelantan Malaysia Email: seempi2005@yahoo.co.uk Chapter 3. Diabetes as an atherogenic factor Dr Sampath Parthasarathy Burnett School of Biomedical Sciences UCF College of Medicine 6900 Lake Nona Blvd.< Orlando Fl 32827 USA Email: spartha@ucf.edu Chapter 4. Effects of diabetes on smooth muscle accumulation in lesions of atherosclerosis Dr L.A. Suzuki Department of Pathology University of Washington Seattle 98195-7470 USA Email: Chapter 5. Genetic basis for increased risk for vascular disease in diabetes Dr Adebowale Adeyemo Center for Research on Genomics and Global Health National Human Genome Research Institute National Institutes of Health Bethesda MD USA Email: adeyemoa@mail.nih.gov SECTION II: Endothelial dysfunction and diabetes Chapter 6. The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes Dr Cristina M. Sena Institute of Physiology Faculty of Medicine University of Coimbra 3000-548 Coimbra Portugal Email: csena@ci.uc.pt Chapter 7. Endothelial dysfunction in hyperglycemia and hyperinsulinemia Professor Madhulika Dixit Department of Biotechnology Indian Institute of Technology Madras Chennai - 600 036 India Email: mdixit@iitm*ac*in Chapter 8. Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing Dr Gopi Krishna Kolluru Department of Pathology LSU Health Sciences Center-Shreveport 1501 Kings Highway LA 71130 USA Email: Chapter 9. Endothelial progenitor cell dysfunction in the pathogenesis of vascular complications of diabetes Dr Adriana Georgescu Institute of Cellular Biology and Pathology 'NicolaeSimionescu' of Romanian Academy 8,B.P.Hasdeu Street PO Box 35-14 Bucharest Romania Email: adriana.georgescu@ icbp.ro< SECTION III: Molecular mechanisms Chapter 10. Mechanisms underlying endothelial dysfunction and impaired vascular reactivity in diabetes mellitus Professor Piruthivi Sukumar Department of Biosciences and Bioengineering Indian Institute of Technology Guwahati Assam - 781039 India Email: p.sukumar@iitg.ernet.in Chapter 11. Nitric oxide synthase pathway in diabetes mellitus Dr Tomoko Asagami Department of Cardiovascular Medicine Stanford University School of Medicine 291 Campus Drive Li Ka Shing Building Stanford CA 94305-5101 USA Email: Chapter 12. The role of endothelin in diabetic vascular complications Dr T. Matsumoto Department of Physiology and Morphology Institute of Medicinal Chemistry Hoshi University< Shinagawa-ku Tokyo 142-8501 Japan Email: t-matsu@hoshi.ac.jp Chapter 13. Oxidative stress and diabetic vascular complications Dr Atsunori Kashiwagi Shiga University of Medical Science Otsu Shiga Japan Email: kasiwagi@belle.shiga-med.ac.jp Chapter 14. Mechanisms of increased vascular superoxide production in human diabetes mellitus Professor Tomasz Guzik Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow G12 8QQ UK Email: Tomasz.Guzik@glasgow.ac.uk Chapter 15. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus Dr Azza B. El-Remessy College of Pharmacy Medical College of Georgia The University of Georgia Augusta GA 30912 Chapter 16. Monocyte derived cytokines and pathogenesis of vascular lesions in diabetes Dr Surya Ramachandran Rajiv Gandhi Center for Biotechnology Thycaud Post Poojappura Thiruvananthapuram - 695 014 Kerala India Email: suryaramachandran@rgcb.res.in Chapter 17. The renin-angiotensin system and the long-term complications of diabetes Professor Jennifer Wilkinson Berka Department of Immunology, Monash Medical School Building Level 5, The Alfred Centre Monash University Melbourne VIC 3004 Australia Email: jennifer.wilkinson-berka@monash.edu Chapter 18. Adipokines and vascular disease in diabetes Professor Camille de Moura Balarini Bioitechnology Center Federal University of Paraiba< Joao Pessoa Brazil Email: SECTION IV: Metabolic factors Chapter 19. Advanced glycation end products and diabetic complications Professor Mark E. Cooper Albert Einstein Juvenile Diabetes Research Foundation Centre for Diabetes Complications Diabetes and Metabolism Division Baker Medical Research Institute P.O. Box 6492 St. Kilda Road Central Melbourne Victoria 8008 Australia Email: mark.cooper@baker.edu.au Chapter 20. Atherogenicdyslipoproteinemia in type 2 diabetes mellitus Professor Rafael Carmena Department of Medicine and Endocrinology University of Valencia Valencia E-46010 Spain Email: Rafael.Carmena@uv.es Chapter 21. Homocysteine and diabetic vasculopathy Professor Martin Buysschaert< Service d'EndocrinologieetNutri-tion CliniquesUniversitaires St. Luc Avenue Hippocrate 54 UCL 54.74 B-1200 Bruxelles Belgium Email : martin.buysschaert@uclouvain.be SECTION V: Hemostatic factors Chapter 22. Diabetes as a prothrombotic condition Professor Peter Grant Academic Unit of Molecular Vascular Medicine Leeds Institute for Genetics, Health and Therapeutics Faculty of Medicine and Health University of Leeds Clarendon Way Leeds LS1 3EX UK Email: P.J.Grant@leeds.ac.uk Chapter 23. Platelet dysfunction in type 2 diabetes Professor Dominick J. Angiolillo Division of Cardiology University of Florida-Jacksonville 5th Floor, Ambulatory Care Center 655 West 8th Street, C35 Jacksonville FL 32209 USA Email: dominick.angiolillo@jax.ufl.edu Chapter 24. Hyperglycemia-induced thrombin formation in diabetes Professor Anetta Undas Institute of Cardiology Jagiellonian University Medical College 80 Pradnicka Street 31-202 Krakow Poland Email: mmundas@cyf-kr.edu.pl Chapter 25. Mechanisms for aberrant clot lysis in diabetic subjects Dr E.J. Dunn Academic Unit of Molecular Vascular Medicine Leeds Institute for Genetics, Health and Therapeutics Faculty of Medicine and Health University of Leeds Clarendon Way Leeds LS1 3EX UK Email: SECTION VI: Diabetic microvasculopathy Chapter 26. Diabetes and retinal vascular disorders Dr Jennifer Wilkinson-Berka Department of Immunology Monash University AMREP Alfred Centre Melbourne Victoria 3004 Australia Email: jennifer.wilkinson-berka@monash.edu Chapter 27. Pericytes and the pathogenesis of diabetic retinopathy Professor Hans Peter Hammes 5th Medical Department University Hospital Mannheim University of Heidelberg Theodor-Kutzer-Ufer 1-3 68167 Mannheim Germany Email: peter.hammes@med5.ma.uni-heidelberg.de Chapter 28. Mechanisms of microvascular damage in human diabetic neuropathy Dr Peter J. Dyck Department of Neurology Mayo Clinic Rochester MN 55905 USA Email: Peter@mayo.edu Chapter 29. Pathogenesis of diabetic nephropathy Dr Stephanie Toth-Manikowski Division of Nephrology Johns Hopkins University 1830 E. Monument Street Suite 416 Baltimore MD 21287 USA Email: stephanie.toth-manikowski@bmc.org SECTION VII: Pharmacological therapies Chapter 30. Mechanisms of action of drugs for treating endothelial dysfunction in diabetes mellitus Dr Sanjay K Banerjee Translational Health Science & Technology Institute NCR Biotech Science Cluster, 3rd Milestone, Faridabad - Gurgaon Expressway, PO box #04, Faridabad - 121001 India Email: skbanerjee@thsti.res.in
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
This book intends to bring together, a panel of renowned experts in the field of vascular biology and diabetology, to integrate the current understanding of the pathogenesis and pathophysiology of vascular diseases in diabetes mellitus.
SECTION I: Pathophysiology Chapter 1. The global burden of diabetes and its vascular complications Dr V. Mohan Madras Diabetes Research Foundation No 4, Conran Smith Road, Gopalapuram, Chennai - 600 086 India Email: drmohans@diabetes.ind.in Chapter 2. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis School of Medical Sciences University Sains Malaysia Kelantan Malaysia Email: seempi2005@yahoo.co.uk Chapter 3. Diabetes as an atherogenic factor Dr Sampath Parthasarathy Burnett School of Biomedical Sciences UCF College of Medicine 6900 Lake Nona Blvd.< Orlando Fl 32827 USA Email: spartha@ucf.edu Chapter 4. Effects of diabetes on smooth muscle accumulation in lesions of atherosclerosis Dr L.A. Suzuki Department of Pathology University of Washington Seattle 98195-7470 USA Email: Chapter 5. Genetic basis for increased risk for vascular disease in diabetes Dr Adebowale Adeyemo Center for Research on Genomics and Global Health National Human Genome Research Institute National Institutes of Health Bethesda MD USA Email: adeyemoa@mail.nih.gov SECTION II: Endothelial dysfunction and diabetes Chapter 6. The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes Dr Cristina M. Sena Institute of Physiology Faculty of Medicine University of Coimbra 3000-548 Coimbra Portugal Email: csena@ci.uc.pt Chapter 7. Endothelial dysfunction in hyperglycemia and hyperinsulinemia Professor Madhulika Dixit Department of Biotechnology Indian Institute of Technology Madras Chennai - 600 036 India Email: mdixit@iitm*ac*in Chapter 8. Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing Dr Gopi Krishna Kolluru Department of Pathology LSU Health Sciences Center-Shreveport 1501 Kings Highway LA 71130 USA Email: Chapter 9. Endothelial progenitor cell dysfunction in the pathogenesis of vascular complications of diabetes Dr Adriana Georgescu Institute of Cellular Biology and Pathology 'NicolaeSimionescu' of Romanian Academy 8,B.P.Hasdeu Street PO Box 35-14 Bucharest Romania Email: adriana.georgescu@ icbp.ro< SECTION III: Molecular mechanisms Chapter 10. Mechanisms underlying endothelial dysfunction and impaired vascular reactivity in diabetes mellitus Professor Piruthivi Sukumar Department of Biosciences and Bioengineering Indian Institute of Technology Guwahati Assam - 781039 India Email: p.sukumar@iitg.ernet.in Chapter 11. Nitric oxide synthase pathway in diabetes mellitus Dr Tomoko Asagami Department of Cardiovascular Medicine Stanford University School of Medicine 291 Campus Drive Li Ka Shing Building Stanford CA 94305-5101 USA Email: Chapter 12. The role of endothelin in diabetic vascular complications Dr T. Matsumoto Department of Physiology and Morphology Institute of Medicinal Chemistry Hoshi University< Shinagawa-ku Tokyo 142-8501 Japan Email: t-matsu@hoshi.ac.jp Chapter 13. Oxidative stress and diabetic vascular complications Dr Atsunori Kashiwagi Shiga University of Medical Science Otsu Shiga Japan Email: kasiwagi@belle.shiga-med.ac.jp Chapter 14. Mechanisms of increased vascular superoxide production in human diabetes mellitus Professor Tomasz Guzik Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow G12 8QQ UK Email: Tomasz.Guzik@glasgow.ac.uk Chapter 15. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus Dr Azza B. El-Remessy College of Pharmacy Medical College of Georgia The University of Georgia Augusta GA 30912 Chapter 16. Monocyte derived cytokines and pathogenesis of vascular lesions in diabetes Dr Surya Ramachandran Rajiv Gandhi Center for Biotechnology Thycaud Post Poojappura Thiruvananthapuram - 695 014 Kerala India Email: suryaramachandran@rgcb.res.in Chapter 17. The renin-angiotensin system and the long-term complications of diabetes Professor Jennifer Wilkinson Berka Department of Immunology, Monash Medical School Building Level 5, The Alfred Centre Monash University Melbourne VIC 3004 Australia Email: jennifer.wilkinson-berka@monash.edu Chapter 18. Adipokines and vascular disease in diabetes Professor Camille de Moura Balarini Bioitechnology Center Federal University of Paraiba< Joao Pessoa Brazil Email: SECTION IV: Metabolic factors Chapter 19. Advanced glycation end products and diabetic complications Professor Mark E. Cooper Albert Einstein Juvenile Diabetes Research Foundation Centre for Diabetes Complications Diabetes and Metabolism Division Baker Medical Research Institute P.O. Box 6492 St. Kilda Road Central Melbourne Victoria 8008 Australia Email: mark.cooper@baker.edu.au Chapter 20. Atherogenicdyslipoproteinemia in type 2 diabetes mellitus Professor Rafael Carmena Department of Medicine and Endocrinology University of Valencia Valencia E-46010 Spain Email: Rafael.Carmena@uv.es Chapter 21. Homocysteine and diabetic vasculopathy Professor Martin Buysschaert< Service d'EndocrinologieetNutri-tion CliniquesUniversitaires St. Luc Avenue Hippocrate 54 UCL 54.74 B-1200 Bruxelles Belgium Email : martin.buysschaert@uclouvain.be SECTION V: Hemostatic factors Chapter 22. Diabetes as a prothrombotic condition Professor Peter Grant Academic Unit of Molecular Vascular Medicine Leeds Institute for Genetics, Health and Therapeutics Faculty of Medicine and Health University of Leeds Clarendon Way Leeds LS1 3EX UK Email: P.J.Grant@leeds.ac.uk Chapter 23. Platelet dysfunction in type 2 diabetes Professor Dominick J. Angiolillo Division of Cardiology University of Florida-Jacksonville 5th Floor, Ambulatory Care Center 655 West 8th Street, C35 Jacksonville FL 32209 USA Email: dominick.angiolillo@jax.ufl.edu Chapter 24. Hyperglycemia-induced thrombin formation in diabetes Professor Anetta Undas Institute of Cardiology Jagiellonian University Medical College 80 Pradnicka Street 31-202 Krakow Poland Email: mmundas@cyf-kr.edu.pl Chapter 25. Mechanisms for aberrant clot lysis in diabetic subjects Dr E.J. Dunn Academic Unit of Molecular Vascular Medicine Leeds Institute for Genetics, Health and Therapeutics Faculty of Medicine and Health University of Leeds Clarendon Way Leeds LS1 3EX UK Email: SECTION VI: Diabetic microvasculopathy Chapter 26. Diabetes and retinal vascular disorders Dr Jennifer Wilkinson-Berka Department of Immunology Monash University AMREP Alfred Centre Melbourne Victoria 3004 Australia Email: jennifer.wilkinson-berka@monash.edu Chapter 27. Pericytes and the pathogenesis of diabetic retinopathy Professor Hans Peter Hammes 5th Medical Department University Hospital Mannheim University of Heidelberg Theodor-Kutzer-Ufer 1-3 68167 Mannheim Germany Email: peter.hammes@med5.ma.uni-heidelberg.de Chapter 28. Mechanisms of microvascular damage in human diabetic neuropathy Dr Peter J. Dyck Department of Neurology Mayo Clinic Rochester MN 55905 USA Email: Peter@mayo.edu Chapter 29. Pathogenesis of diabetic nephropathy Dr Stephanie Toth-Manikowski Division of Nephrology Johns Hopkins University 1830 E. Monument Street Suite 416 Baltimore MD 21287 USA Email: stephanie.toth-manikowski@bmc.org SECTION VII: Pharmacological therapies Chapter 30. Mechanisms of action of drugs for treating endothelial dysfunction in diabetes mellitus Dr Sanjay K Banerjee Translational Health Science & Technology Institute NCR Biotech Science Cluster, 3rd Milestone, Faridabad - Gurgaon Expressway, PO box #04, Faridabad - 121001 India Email: skbanerjee@thsti.res.in
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
